R C Walovitch

MS-325: albumin-targeted contrast agent for MR angiography.

R. Dolan, R. Lauffer, R. Walovitch, 1998, Radiology.

Three‐dimensional MRI of coronary arteries using an intravascular contrast agent

R. Dolan, Debiao Li, R. Lauffer, 1998, Magnetic resonance in medicine.

Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans.

G Demonceau, R Taillefer, M De Roo, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Steady-state and dynamic MR angiography with MS-325: initial experience in humans.

D C Peters, T M Grist, F R Korosec, 1998, Radiology.

Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging.

R. Lauffer, R. Walovitch, R B Lauffer, 1997, Investigative radiology.

Studies of the retention mechanism of the brain perfusion imaging agent 99mTc-bicisate (99mTc-ECD).

R. Walovitch, R C Walovitch, E. Cheesman, 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Radio-frequency-induced coagulation necrosis in rabbits: immediate detection at US with a synthetic microsphere contrast agent.

G S Gazelle, G. Gazelle, S. Goldberg, 1999, Radiology.

Radiolabeled agents for SPECT imaging of brain perfusion.

R. Walovitch, R C Walovitch, S. Williams, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates.

D. O'leary, R. Walovitch, T C Hill, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intravascular contrast agent improves magnetic resonance angiography of carotid arteries in minipigs

E M Haacke, R. Dolan, E. Haacke, 1997, Journal of magnetic resonance imaging : JMRI.